BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Garske T, Ghani AC. Uncertainty in the tail of the variant Creutzfeldt-Jakob disease epidemic in the UK. PLoS One 2010;5:e15626. [PMID: 21203419 DOI: 10.1371/journal.pone.0015626] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 McManus H, Seed CR, Hoad VC, Kiely P, Kaldor JM, Styles CE, Yang H, Law M, Gosbell IB. Risk of variant Creutzfeldt-Jakob disease transmission by blood transfusion in Australia. Vox Sang 2022. [PMID: 35609012 DOI: 10.1111/vox.13290] [Reference Citation Analysis]
2 Ritchie DL, Peden AH, Barria MA. Variant CJD: Reflections a Quarter of a Century on. Pathogens 2021;10:1413. [PMID: 34832569 DOI: 10.3390/pathogens10111413] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Watson N, Brandel JP, Green A, Hermann P, Ladogana A, Lindsay T, Mackenzie J, Pocchiari M, Smith C, Zerr I, Pal S. The importance of ongoing international surveillance for Creutzfeldt-Jakob disease. Nat Rev Neurol 2021;17:362-79. [PMID: 33972773 DOI: 10.1038/s41582-021-00488-7] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
4 Bélondrade M, Jas-Duval C, Nicot S, Bruyère-Ostells L, Mayran C, Herzog L, Reine F, Torres JM, Fournier-Wirth C, Béringue V, Lehmann S, Bougard D. Correlation between Bioassay and Protein Misfolding Cyclic Amplification for Variant Creutzfeldt-Jakob Disease Decontamination Studies. mSphere 2020;5:e00649-19. [PMID: 31996421 DOI: 10.1128/mSphere.00649-19] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
5 Bougard D, Bélondrade M, Mayran C, Bruyère-Ostells L, Lehmann S, Fournier-Wirth C, Knight RS, Will RG, Green AJE. Diagnosis of Methionine/Valine Variant Creutzfeldt-Jakob Disease by Protein Misfolding Cyclic Amplification. Emerg Infect Dis 2018;24:1364-6. [PMID: 29912702 DOI: 10.3201/eid2407.172105] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
6 Soto C, Pritzkow S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci 2018;21:1332-40. [PMID: 30250260 DOI: 10.1038/s41593-018-0235-9] [Cited by in Crossref: 292] [Cited by in F6Publishing: 365] [Article Influence: 73.0] [Reference Citation Analysis]
7 Douet JY, Lacroux C, Aron N, Head MW, Lugan S, Tillier C, Huor A, Cassard H, Arnold M, Beringue V, Ironside JW, Andréoletti O. Distribution and Quantitative Estimates of Variant Creutzfeldt-Jakob Disease Prions in Tissues of Clinical and Asymptomatic Patients. Emerg Infect Dis 2017;23:946-56. [PMID: 28518033 DOI: 10.3201/eid2306.161734] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
8 Coulthart MB, Geschwind MD, Qureshi S, Phielipp N, Demarsh A, Abrams JY, Belay E, Gambetti P, Jansen GH, Lang AE, Schonberger LB. A case cluster of variant Creutzfeldt-Jakob disease linked to the Kingdom of Saudi Arabia. Brain 2016;139:2609-16. [PMID: 27671029 DOI: 10.1093/brain/aww206] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
9 Seed CR, Hewitt PE, Dodd RY, Houston F, Cervenakova L. Creutzfeldt-Jakob disease and blood transfusion safety. Vox Sang 2018;113:220-31. [DOI: 10.1111/vox.12631] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
10 Will RG, Ironside JW. Sporadic and Infectious Human Prion Diseases. Cold Spring Harb Perspect Med 2017;7:a024364. [PMID: 27793965 DOI: 10.1101/cshperspect.a024364] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
11 Donaldson DS, Mabbott NA. The influence of the commensal and pathogenic gut microbiota on prion disease pathogenesis. J Gen Virol 2016;97:1725-38. [PMID: 27193137 DOI: 10.1099/jgv.0.000507] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
12 Maheshwari A, Fischer M, Gambetti P, Parker A, Ram A, Soto C, Concha-Marambio L, Cohen Y, Belay ED, Maddox RA, Mead S, Goodman C, Kass JS, Schonberger LB, Hussein HM. Recent US Case of Variant Creutzfeldt-Jakob Disease-Global Implications. Emerg Infect Dis 2015;21:750-9. [PMID: 25897712 DOI: 10.3201/eid2105.142017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
13 Sawyer EB, Edgeworth JA, Thomas C, Collinge J, Jackson GS. Preclinical detection of infectivity and disease-specific PrP in blood throughout the incubation period of prion disease. Sci Rep 2015;5:17742. [PMID: 26631638 DOI: 10.1038/srep17742] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
14 Garraud O, Morel P, Coste J, Tiberghien P, Fournier-wirth C. Transfusion sanguine : un modèle de questionnement en recherche et développement. La Presse Médicale 2015;44:233-40. [DOI: 10.1016/j.lpm.2014.06.039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 McDowell KL, Nag N, Franco Z, Bu M, Piccardo P, Cervenak J, Deslys JP, Comoy E, Asher DM, Gregori L. Blood reference materials from macaques infected with variant Creutzfeldt-Jakob disease agent. Transfusion 2015;55:405-12. [PMID: 25154296 DOI: 10.1111/trf.12841] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
16 Lacroux C, Comoy E, Moudjou M, Perret-Liaudet A, Lugan S, Litaise C, Simmons H, Jas-Duval C, Lantier I, Béringue V, Groschup M, Fichet G, Costes P, Streichenberger N, Lantier F, Deslys JP, Vilette D, Andréoletti O. Preclinical detection of variant CJD and BSE prions in blood. PLoS Pathog 2014;10:e1004202. [PMID: 24945656 DOI: 10.1371/journal.ppat.1004202] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 9.5] [Reference Citation Analysis]
17 Chen CC, Wang YH. Estimation of the exposure of the UK population to the bovine spongiform encephalopathy agent through dietary intake during the period 1980 to 1996. PLoS One 2014;9:e94020. [PMID: 24736322 DOI: 10.1371/journal.pone.0094020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
18 Yang H, Gregori L, Asher DM, Epstein JS, Anderson SA. Risk assessment for transmission of variant Creutzfeldt-Jakob disease by transfusion of red blood cells in the United States: vCJD risk Assessment in RBC Recipients. Transfusion 2014;54:2194-201. [DOI: 10.1111/trf.12637] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
19 Brown KL, Mabbott NA. Evidence of subclinical prion disease in aged mice following exposure to bovine spongiform encephalopathy. J Gen Virol 2014;95:231-43. [PMID: 24123519 DOI: 10.1099/vir.0.058958-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
20 Gill ON, Spencer Y, Richard-Loendt A, Kelly C, Dabaghian R, Boyes L, Linehan J, Simmons M, Webb P, Bellerby P, Andrews N, Hilton DA, Ironside JW, Beck J, Poulter M, Mead S, Brandner S. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ 2013;347:f5675. [PMID: 24129059 DOI: 10.1136/bmj.f5675] [Cited by in Crossref: 185] [Cited by in F6Publishing: 153] [Article Influence: 20.6] [Reference Citation Analysis]
21 Bishop MT, Sanchez-Juan P, Knight RS. Splice site SNPs of phospholipase PLCXD3 are significantly associated with variant and sporadic Creutzfeldt-Jakob disease. BMC Med Genet 2013;14:91. [PMID: 24028506 DOI: 10.1186/1471-2350-14-91] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
22 Coste J. Symposium on prions and transfusion safety. Transfusion Clinique et Biologique 2013;20:393-4. [DOI: 10.1016/j.tracli.2013.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
23 Thomas S, Turner ML, Williamson LM. UK approach to assessing assays and filters designed to reduce the risk of transfusion-transmitted vCJD. Transfus Clin Biol 2013;20:405-11. [PMID: 23928183 DOI: 10.1016/j.tracli.2013.05.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Segarra C, Bougard D, Moudjou M, Laude H, Béringue V, Coste J. Plasminogen-based capture combined with amplification technology for the detection of PrP(TSE) in the pre-clinical phase of infection. PLoS One 2013;8:e69632. [PMID: 23894513 DOI: 10.1371/journal.pone.0069632] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
25 Bishop MT, Diack AB, Ritchie DL, Ironside JW, Will RG, Manson JC. Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt-Jakob disease. Brain 2013;136:1139-45. [PMID: 23449776 DOI: 10.1093/brain/awt032] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
26 Head MW. Human prion diseases: Molecular, cellular and population biology: Human prion diseases. Neuropathology 2013;33:221-36. [DOI: 10.1111/neup.12016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
27 Elebute MO, Choo L, Mora A, MacRury C, Llewelyn C, Purohit S, Hicks V, Casey C, Malfroy M, Deary A, Reed T, Meredith S, Manson L, Williamson LM. Transfusion of prion-filtered red cells does not increase the rate of alloimmunization or transfusion reactions in patients: results of the UK trial of prion-filtered versus standard red cells in surgical patients (PRISM A). Br J Haematol 2013;160:701-8. [PMID: 23294293 DOI: 10.1111/bjh.12188] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
28 Hervé R, Keevil CW. Current limitations about the cleaning of luminal endoscopes. J Hosp Infect 2013;83:22-9. [PMID: 23098682 DOI: 10.1016/j.jhin.2012.08.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
29 Lacroux C, Bougard D, Litaise C, Simmons H, Corbiere F, Dernis D, Tardivel R, Morel N, Simon S, Lugan S, Costes P, Weisbecker JL, Schelcher F, Grassi J, Coste J, Andréoletti O. Impact of leucocyte depletion and prion reduction filters on TSE blood borne transmission. PLoS One 2012;7:e42019. [PMID: 22860049 DOI: 10.1371/journal.pone.0042019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
30 Millar CM, Makris M. Dealing with the uncertain risk of variant Creutzfeldt-Jakob disease transmission by coagulation replacement products. Br J Haematol 2012;158:442-52. [DOI: 10.1111/j.1365-2141.2012.09201.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
31 Wisniewski T, Goñi F. Could immunomodulation be used to prevent prion diseases? Expert Rev Anti Infect Ther 2012;10:307-17. [PMID: 22397565 DOI: 10.1586/eri.11.177] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
32 Andrychowski J, Jasielski P, Netczuk T, Czernicki Z. Empyema in spinal canal in thoracic region, abscesses in paravertebral space, spondylitis: in clinical course of zoonosis Erysipelothrix rhusiopathiae. Eur Spine J 2012;21 Suppl 4:S557-63. [PMID: 22526696 DOI: 10.1007/s00586-012-2289-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
33 Teljeur C, Flattery M, Harrington P, O'neill M, Moran PS, Murphy L, Ryan M. Cost-effectiveness of prion filtration of red blood cells to reduce the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease in the Republic of Ireland: COST-EFFECTIVENESS OF PRION FILTRATION. Transfusion 2012;52:2285-93. [DOI: 10.1111/j.1537-2995.2012.03637.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
34 Brandel JP, Welaratne A, Salomon D, Capek I, Vaillant V, Aouba A, Haïk S, Alpérovitch A. Can mortality data provide reliable indicators for Creutzfeldt-Jakob disease surveillance? A study in France from 2000 to 2008. Neuroepidemiology 2011;37:188-92. [PMID: 22057088 DOI: 10.1159/000332764] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]